Rheumatology Associates participates in clinical trials to offer additional options to patients who have tried various drugs without benefit, or otherwise may not have access to treatment.
Rheumatology Associates conducts clinical trials according to Good Clinical Practice (GCP) Guidelines issued by the Food and Drug Administration (FDA) and the Code of Federal Regulations. We participate in multiple Phase II to Phase IV pharmaceutical trials, on an outpatient basis. Many of our physicians have attended Investigator GCP Training Seminars and our research manager is a Certified Clinical Research Coordinator. Specific areas of interest include Rheumatoid Arthritis, Psoriatic Arthritis, Gout, Osteoarthritis, Osteoporosis, and Systemic Lupus.
Principle Investigator: Pamela G. Freeman, M.D.
Research Manager: Tina Mellenberndt, NCMA, BMO, CDT, CCRC
Participation in clinical trials is voluntary, patients are evaluated by the Principle Investigator or Sub-Investigators at protocol specific intervals.
Procedures involved in clinical trials may include: X-rays, EKG, Physical Exam, Joint Assessments, lab work. Depending on the protocol, procedures may also include injection or infusion of drug. These procedures are performed at no cost to the patient and many trials provide reimbursement to the subject for their time and travel to visits.
Further information about current clinical trials can be obtained by calling 407-859-4540 or email to firstname.lastname@example.org and put “research” in the subject line.